Metallothionein provides ubiquinone-mediated neuroprotection in Parkinson's disease.

Authors :: Ebadi M
Sharma S
Muralikrishnan D
Shavali S
Eken J
Sangchot P
Chetsawang B
Brekke L
Source :: Proceedings of the Western Pharmacology Society [Proc West Pharmacol Soc] 2002; Vol. 45, pp. 36-8.
Publication Year :: 2002

Subjects :: Animals
Brain drug effects
Humans
Mitochondria drug effects
Neurodegenerative Diseases pathology
Neurodegenerative Diseases prevention & control
Oxidative Phosphorylation drug effects
Parkinson Disease metabolism
Ubiquinone metabolism
Metallothionein pharmacology
Neuroprotective Agents pharmacology
Parkinson Disease pathology
Ubiquinone physiology

Tools